Senate Urges CMS to Reconsider ESA Policy
|
|
On September 4th, 2007, the U.S. Senate approved a resolution (S. Res. 305) asking the Centers for Medicare & Medicaid Services (CMS) to revisit a recent policy change that restricted payments for certain anti-anemia medications when used in cancer patients. The resolution, introduced by Senator Arlen Specter (R-PA), asks CMS to implement appropriate revisions to the final Medicare National Coverage Determination on the Use of Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions "as soon as feasible and provide a briefing to Congress in advance of announcing such changes."
Full Text of Resolution
|